Novavax reported $71.36M in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Adamas Pharmaceuticals ADMS:US 10.1M 2.32M
Adma Biologics ADMA:US $ 23.54M 8.18M
Agenus AGEN:US $ 1.44M 0.74M
AstraZeneca AZN:LN 6.84B 214M
Astrazeneca AZN:US 6.84B 214M
Biocryst Pharmaceuticals BCRX:US $ 27.62M 9.23M
Dynavax Technologies DVAX:US $ 105.9M 21.91M
GlaxoSmithKline GSK:LN 7.51B 324M
Kindred Biosciences KIN:US 1.56M 11.16M
Mannkind MNKD:US $ 6.3M 2.73M
Moderna Inc MRNA:US 2.07B 1.16B
Novartis NVS:US $ 8654M 173M
Novavax NVAX:US $ 71.36M 30.83M
Peregrine Pharmaceuticals PPHM:US $ 24.31M 0.64M
Sarepta Therapeutics SRPT:US $ 148.26M 11.9M